Serina Therapeutics, Inc. Public Float
Serina Therapeutics, Inc. (SER) had Public Float of $21.80 million as of 2025-06-30, per its 10-K/A filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $21.80M.
- 2024-06-30: Entity Public Float $38.40M.
- 2023-06-30: Entity Public Float $18.70M.
- 2022-06-30: Entity Public Float $12.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $21.80M 10-K/A · filed 2026-03-27 |
| 2024-06-30 | $38.40M 10-K · filed 2025-03-24 |
| 2023-06-30 | $18.70M 10-K · filed 2024-03-22 |
| 2022-06-30 | $12.10M 10-K · filed 2023-03-31 |
| 2021-06-30 | $32.50M 10-K · filed 2022-03-29 |
| 2020-06-30 | $19.60M 10-K · filed 2021-03-31 |
| 2019-06-30 | $56.40M 10-K/A · filed 2020-03-31 |
| 2018-06-30 | $0.00 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |